The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges

Digital

Autores:

Eikelboom, John
Rangarajan, Sumathy
Jolly, Sanjit S.
Belley-Cote, Emilie P.
Whitlock, Richard
Beresh, Heather
Lewis, Gayle
Xu, Lizhen
Chan, Noel
Bangdiwala, Shrikant
Diaz, Rafael
Orlandini, Andres
Hassany, Mohamed
Tarhuni, Wadea M.
Yusufali, A.M.
Sharma, Sanjib Kumar
Kontsevaya, Anna
Lopez-Jaramillo, Patricio
Avezum, Alvaro
Dans, Antonio L.
Wasserman, Sean
Felix, Camilo
Kazmi, Khawar
Pais, Prem
Xavier, Denis
Lopes, Renato D.
Berwanger, Otavio
Nkeshimana, Menelas
Harper, William
Loeb, Mark
Choudhri, Shurjeel
Farkouh, Michael E.
Bosch, Jackie
Anand, Sonia S.
Yusuf, Salim

Tipo de recurso:

Article of journal

Fecha de publicación:

2022

Institución:

Universidad de Santander

Repositorio:

Repositorio Universidad de Santander

Idioma:

eng

OAI Identifier:

oai:repositorio.udes.edu.co:001/7446

Acceso en línea:

https://doi.org/10.1016/j.cjco.2022.02.010
https://repositorio.udes.edu.co/handle/001/7446

Palabra clave:

Rights

openAccess

License

© 2022 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.